vs
Ingevity Corp（NGVT）とPennant Group, Inc.（PNTG）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pennant Group, Inc.の直近四半期売上が大きい（$289.3M vs $185.4M、Ingevity Corpの約1.6倍）。Pennant Group, Inc.の純利益率が高く（3.0% vs -45.6%、差は48.6%）。Pennant Group, Inc.の前年同期比売上増加率が高い（53.2% vs 36.7%）。Ingevity Corpの直近四半期フリーキャッシュフローが多い（$73.5M vs $17.4M）。過去8四半期でPennant Group, Inc.の売上複合成長率が高い（35.8% vs -26.2%）
インジェビティコープは世界的な特殊化学品・先端材料メーカーで、高性能炭素材料、舗装保全ソリューション、特殊化学製品を生産しています。自動車排出ガス制御、工業浄化、道路インフラ、農業資材を主要市場とし、事業は北米、欧州、アジア太平洋地域に展開しています。
ペナントグループ株式会社は米国に本社を置く医療サービス事業者で、在宅医療、ホスピスケア、高齢者向け居住ソリューション、熟練看護支援を提供しています。米国の数十州で事業を展開し、主に高齢者や医療的ケアを必要とする弱者層を対象としてサービスを提供しています。
NGVT vs PNTG — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $185.4M | $289.3M |
| 純利益 | $-84.6M | $8.6M |
| 粗利率 | 41.2% | — |
| 営業利益率 | -47.7% | 6.0% |
| 純利益率 | -45.6% | 3.0% |
| 売上前年比 | 36.7% | 53.2% |
| 純利益前年比 | -609.6% | 50.0% |
| EPS（希薄化後） | $-2.33 | $0.25 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $185.4M | $289.3M | ||
| Q3 25 | $333.1M | $229.0M | ||
| Q2 25 | $365.1M | $219.5M | ||
| Q1 25 | $284.0M | $209.8M | ||
| Q4 24 | $135.6M | $188.9M | ||
| Q3 24 | $333.8M | $180.7M | ||
| Q2 24 | $390.6M | $168.7M | ||
| Q1 24 | $340.1M | $156.9M |
| Q4 25 | $-84.6M | $8.6M | ||
| Q3 25 | $43.5M | $6.1M | ||
| Q2 25 | $-146.5M | $7.1M | ||
| Q1 25 | $20.5M | $7.8M | ||
| Q4 24 | $16.6M | $5.8M | ||
| Q3 24 | $-107.2M | $6.2M | ||
| Q2 24 | $-283.7M | $5.7M | ||
| Q1 24 | $-56.0M | $4.9M |
| Q4 25 | 41.2% | — | ||
| Q3 25 | 40.2% | — | ||
| Q2 25 | 37.8% | — | ||
| Q1 25 | 39.9% | — | ||
| Q4 24 | 81.3% | — | ||
| Q3 24 | 39.4% | — | ||
| Q2 24 | 31.5% | — | ||
| Q1 24 | 29.3% | — |
| Q4 25 | -47.7% | 6.0% | ||
| Q3 25 | 18.7% | 4.5% | ||
| Q2 25 | -39.1% | 5.3% | ||
| Q1 25 | 9.4% | 6.0% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | 33.0% | 6.0% | ||
| Q2 24 | 25.9% | 5.7% | ||
| Q1 24 | 22.6% | 5.4% |
| Q4 25 | -45.6% | 3.0% | ||
| Q3 25 | 13.1% | 2.7% | ||
| Q2 25 | -40.1% | 3.2% | ||
| Q1 25 | 7.2% | 3.7% | ||
| Q4 24 | 12.2% | 3.0% | ||
| Q3 24 | -32.1% | 3.4% | ||
| Q2 24 | -72.6% | 3.4% | ||
| Q1 24 | -16.5% | 3.1% |
| Q4 25 | $-2.33 | $0.25 | ||
| Q3 25 | $1.18 | $0.17 | ||
| Q2 25 | $-4.02 | $0.20 | ||
| Q1 25 | $0.56 | $0.22 | ||
| Q4 24 | $0.44 | $0.16 | ||
| Q3 24 | $-2.94 | $0.20 | ||
| Q2 24 | $-7.81 | $0.18 | ||
| Q1 24 | $-1.54 | $0.16 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $78.1M | — |
| 総負債低いほど良い | $1.2B | $168.8M |
| 株主資本純資産 | $29.7M | $374.3M |
| 総資産 | $1.7B | $968.2M |
| 負債/資本比率低いほどレバレッジが低い | 39.10× | 0.45× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $78.1M | — | ||
| Q3 25 | $83.4M | — | ||
| Q2 25 | $76.9M | — | ||
| Q1 25 | $71.5M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $135.5M | — | ||
| Q2 24 | $107.4M | — | ||
| Q1 24 | $88.5M | — |
| Q4 25 | $1.2B | $168.8M | ||
| Q3 25 | $1.2B | $26.0M | ||
| Q2 25 | $1.2B | $37.0M | ||
| Q1 25 | $1.3B | $52.5M | ||
| Q4 24 | $1.3B | $0 | ||
| Q3 24 | $1.4B | $108.9M | ||
| Q2 24 | $1.4B | $82.2M | ||
| Q1 24 | $1.4B | $83.3M |
| Q4 25 | $29.7M | $374.3M | ||
| Q3 25 | $138.1M | $343.0M | ||
| Q2 25 | $120.7M | $333.6M | ||
| Q1 25 | $234.6M | $323.0M | ||
| Q4 24 | $195.2M | $312.0M | ||
| Q3 24 | $214.5M | $187.3M | ||
| Q2 24 | $284.8M | $173.0M | ||
| Q1 24 | $568.2M | $164.2M |
| Q4 25 | $1.7B | $968.2M | ||
| Q3 25 | $1.8B | $753.6M | ||
| Q2 25 | $1.9B | $751.4M | ||
| Q1 25 | $2.1B | $743.6M | ||
| Q4 24 | $2.0B | $679.5M | ||
| Q3 24 | $2.2B | $646.8M | ||
| Q2 24 | $2.3B | $602.5M | ||
| Q1 24 | $2.6B | $578.2M |
| Q4 25 | 39.10× | 0.45× | ||
| Q3 25 | 8.39× | 0.08× | ||
| Q2 25 | 10.24× | 0.11× | ||
| Q1 25 | 5.68× | 0.16× | ||
| Q4 24 | 6.86× | 0.00× | ||
| Q3 24 | 6.52× | 0.58× | ||
| Q2 24 | 4.92× | 0.48× | ||
| Q1 24 | 2.48× | 0.51× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $97.1M | $21.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $73.5M | $17.4M |
| FCFマージンFCF / 売上 | 39.6% | 6.0% |
| 設備投資強度設備投資 / 売上 | 12.7% | 1.2% |
| キャッシュ転換率営業CF / 純利益 | — | 2.43× |
| 直近12ヶ月FCF直近4四半期 | $273.5M | $36.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $97.1M | $21.0M | ||
| Q3 25 | $129.7M | $13.9M | ||
| Q2 25 | $79.0M | $34.6M | ||
| Q1 25 | $25.4M | $-21.2M | ||
| Q4 24 | $64.5M | $20.6M | ||
| Q3 24 | $46.5M | $7.7M | ||
| Q2 24 | $29.7M | $10.5M | ||
| Q1 24 | $-12.1M | $545.0K |
| Q4 25 | $73.5M | $17.4M | ||
| Q3 25 | $117.8M | $10.5M | ||
| Q2 25 | $66.8M | $31.6M | ||
| Q1 25 | $15.4M | $-23.2M | ||
| Q4 24 | $39.6M | $17.2M | ||
| Q3 24 | $28.5M | $6.8M | ||
| Q2 24 | $11.6M | $8.9M | ||
| Q1 24 | $-28.7M | $-2.6M |
| Q4 25 | 39.6% | 6.0% | ||
| Q3 25 | 35.4% | 4.6% | ||
| Q2 25 | 18.3% | 14.4% | ||
| Q1 25 | 5.4% | -11.1% | ||
| Q4 24 | 29.2% | 9.1% | ||
| Q3 24 | 8.5% | 3.8% | ||
| Q2 24 | 3.0% | 5.3% | ||
| Q1 24 | -8.4% | -1.7% |
| Q4 25 | 12.7% | 1.2% | ||
| Q3 25 | 3.6% | 1.5% | ||
| Q2 25 | 3.3% | 1.4% | ||
| Q1 25 | 3.5% | 0.9% | ||
| Q4 24 | 18.4% | 1.8% | ||
| Q3 24 | 5.4% | 0.5% | ||
| Q2 24 | 4.6% | 1.0% | ||
| Q1 24 | 4.9% | 2.0% |
| Q4 25 | — | 2.43× | ||
| Q3 25 | 2.98× | 2.29× | ||
| Q2 25 | — | 4.89× | ||
| Q1 25 | 1.24× | -2.73× | ||
| Q4 24 | 3.89× | 3.57× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.84× | ||
| Q1 24 | — | 0.11× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NGVT
| Performance Materials | $151.2M | 82% |
| Advanced Polymer Technologies Segment | $36.5M | 20% |
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
